KANZHUN LIMITED - American Depo (BZ) Q2 2026 earnings — TrendMatrix coverage
BEAT+2.9% vs estimateEPS $2.23 vs $2.17 estVerdict Strong Buy → Buy (Wait)
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Event detail · Q2 2026
Key numbers
- Adjusted EPS
- $2.23
- Estimate
- $2.17
- Surprise
- +2.9%
- Score at report (before → after)
- 7.1 → 6.9/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
Report record · Q2 2026
How the report landed
KANZHUN LIMITED - American Depo (BZ) beat the $2.17 estimate with adjusted EPS of $2.23 — a modest 2.9% upside surprise. TrendMatrix's engine moved from Strong Buy (7.1/10) to Buy (Wait) at 6.9/10 after the report — the engine's score fell despite the beat.
Around the report
Coverage in the report window
- Barclays Maintains Overweight on Kanzhun, Raises Price Target to $20 — benzinga, 2026-08-27
- Abercrombie & Fitch Posts Upbeat Q2 Results, Joins Semtech, Summit Therapeutics And Other Big Stocks Moving Higher On We — benzinga, 2026-08-26
- Transcript: Kanzhun Q2 2026 Earnings Conference Call — benzinga, 2026-08-25